Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Aerpio Therapeutics Inc patents


Recent patent applications related to Aerpio Therapeutics Inc. Aerpio Therapeutics Inc is listed as an Agent/Assignee. Note: Aerpio Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Aerpio Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Aerpio Therapeutics Inc-related inventors


Compositions, formulations and methods for treating ocular diseases

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. ... Aerpio Therapeutics Inc

Compositions, formulations and methods for treating ocular diseases

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. ... Aerpio Therapeutics Inc

Compositions, formulations and methods for treating ocular diseases

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. ... Aerpio Therapeutics Inc

Compositions, formulations and methods for treating ocular diseases

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. ... Aerpio Therapeutics Inc

Human protein tyrosine phosphatase inhibitors and methods of use

The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (hptp-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (hptp-β) inhibitors, and to methods for regulating angiogenesis.. ... Aerpio Therapeutics Inc

Phosphatase inhibitors for treating ocular diseases

Disclosed are compounds and pharmaceutical compositions effective for inhibition of hptp-β. The compounds can provide effective therapy for ocular disease, for example, ocular edema and ocular neovascularization.. ... Aerpio Therapeutics Inc

Treatment of ocular disease

Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.. . ... Aerpio Therapeutics Inc

Compositions and methods for treating ocular edema, neovascularization and related diseases

Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like.. ... Aerpio Therapeutics Inc

Humanized monoclonal antibodies that target ve-ptp (hptp-beta)

The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.. . ... Aerpio Therapeutics Inc

Compositions, formulations and methods for treating ocular diseases

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. ... Aerpio Therapeutics Inc

Methods for treating vascular leak syndrome

Disclosed are methods for treating vascular leak syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. ... Aerpio Therapeutics Inc

Methods for treating vascular leak syndrome and cancer

Disclosed are methods for treating vascular leak syndrome and preventing cancer metastasis. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, sepsis, cancer or the presence of pathogens.. ... Aerpio Therapeutics Inc

Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof

Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (hptpβ), and uses thereof.. . ... Aerpio Therapeutics Inc

Compositions and methods for treating ocular diseases

Disclosed herein are compositions and methods for treating ocular diseases, inter alia, diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like. These diseases or conditions are characterized by changes in the ocular vasculature whether progressive or non-progressive, whether a result of an acute disease or condition, or a chronic disease or condition.. ... Aerpio Therapeutics Inc

03/23/17 / #20170079959

Methods of treating intraocular pressure with activators of tie-2

Disclosed herein are compounds effective for activation of tie-2 and inhibition of hptp-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.. ... Aerpio Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Aerpio Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aerpio Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###